Together, we reach far beyond the skin
Putting innovation into practice
with an extensive global portfolio of treatments in medical dermatology
Lifting the burden of disease
for nearly 100 million people who rely on our medicines every year
Shaping the future of what’s next
in partnership with healthcare organizations, scientists and patient groups
PRESS RELEASE
LEO Pharma to present at the 44th annual J.P. Morgan Healthcare Conference
LEO Pharma announced that CEO Christophe Bourdon will present a company update at the 44th J.P. Morgan Healthcare Conference in San Francisco on January 13, 2026, at 9:30 AM PST.
Ballerup, Denmark, January 7, 2026
Learn moreMORE NEWS
- Jan 07 2026 LEO Pharma to present at the 44th annual J.P. Morgan Healthcare Conference
- Dec 16 2025 LEO Pharma appoints Marika Murto to lead Global Product Strategy
- Dec 15 2025 LEO Pharma submits adolescent label expansion application for Anzupgo® to EMA
ANNUAL REPORT 2024
LEO Pharma delivers double-digit revenue growth
LEO Pharma delivered another year of strong progress in 2024, with both sales growth and adjusted EBITDA margin ahead of the initial outlook for the year, putting the company on track to meet its profitability targets and to achieve its long-term strategic objectives.
Read more
CAREER
Discover how we innovate collectively.
For us, collaborating innovatively means continuously enhancing and expanding what's achievable for one another, our company, and our patients.